Pjotr P Temme, Matthijs van Luin, Maarten J Deenen, Ron Meijer, Nynke G L Jager, Mirte M Malingré
{"title":"Influence of ultrafiltration conditions on the unbound fraction of phenytoin and valproic acid.","authors":"Pjotr P Temme, Matthijs van Luin, Maarten J Deenen, Ron Meijer, Nynke G L Jager, Mirte M Malingré","doi":"10.1007/s00228-025-03918-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study was designed to analyse the influence of temperature, pH and storage time on unbound fractions of PHT and VPA.</p><p><strong>Methods: </strong>The influence of ultrafiltration (UF) temperature on measured unbound fractions of PHT and VPA in spiked samples was evaluated in a single laboratory experiment and in data from a national external quality control (EQC) database. The influence of pH adjustment with phosphate buffered saline (PBS) on measured unbound fractions of PHT and VPA was investigated in patient samples. The influence of storage time on unbound fractions of PHT and VPA was examined in patient samples by performing UF at various time points.</p><p><strong>Results: </strong>Performing UF at a temperature of 37 °C compared to 20 °C significantly increased (p < 0.05) the measured unbound fractions for both PHT (range 14.8-26.3%) and VPA (range 5.7-16.0%) in the single laboratory experiment. Consistent with these findings, reported unbound fractions in the ECQ database of PHT were significantly higher with UF at 37 °C compared to room temperature. For VPA, this was not the case. However, for both drugs, the number of laboratories performing UF at 37 °C was limited (n = 2-4). Adjustment of pH with PBS was unfeasible. After 4 days of storage at 5 °C, the unbound fraction of PHT seemed to remain stable whereas the unbound fraction of VPA appeared to increase (27.4%) (n = 3).</p><p><strong>Conclusion: </strong>Higher UF temperatures led to an increase in measured unbound fractions of both PHT and to a lesser extent VPA. Storage time of plasma samples might influence the unbound fraction of VPA.</p>","PeriodicalId":11857,"journal":{"name":"European Journal of Clinical Pharmacology","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00228-025-03918-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: This study was designed to analyse the influence of temperature, pH and storage time on unbound fractions of PHT and VPA.
Methods: The influence of ultrafiltration (UF) temperature on measured unbound fractions of PHT and VPA in spiked samples was evaluated in a single laboratory experiment and in data from a national external quality control (EQC) database. The influence of pH adjustment with phosphate buffered saline (PBS) on measured unbound fractions of PHT and VPA was investigated in patient samples. The influence of storage time on unbound fractions of PHT and VPA was examined in patient samples by performing UF at various time points.
Results: Performing UF at a temperature of 37 °C compared to 20 °C significantly increased (p < 0.05) the measured unbound fractions for both PHT (range 14.8-26.3%) and VPA (range 5.7-16.0%) in the single laboratory experiment. Consistent with these findings, reported unbound fractions in the ECQ database of PHT were significantly higher with UF at 37 °C compared to room temperature. For VPA, this was not the case. However, for both drugs, the number of laboratories performing UF at 37 °C was limited (n = 2-4). Adjustment of pH with PBS was unfeasible. After 4 days of storage at 5 °C, the unbound fraction of PHT seemed to remain stable whereas the unbound fraction of VPA appeared to increase (27.4%) (n = 3).
Conclusion: Higher UF temperatures led to an increase in measured unbound fractions of both PHT and to a lesser extent VPA. Storage time of plasma samples might influence the unbound fraction of VPA.
期刊介绍：
The European Journal of Clinical Pharmacology publishes original papers on all aspects of clinical pharmacology and drug therapy in humans. Manuscripts are welcomed on the following topics: therapeutic trials, pharmacokinetics/pharmacodynamics, pharmacogenetics, drug metabolism, adverse drug reactions, drug interactions, all aspects of drug development, development relating to teaching in clinical pharmacology, pharmacoepidemiology, and matters relating to the rational prescribing and safe use of drugs. Methodological contributions relevant to these topics are also welcomed.
Data from animal experiments are accepted only in the context of original data in man reported in the same paper. EJCP will only consider manuscripts describing the frequency of allelic variants in different populations if this information is linked to functional data or new interesting variants. Highly relevant differences in frequency with a major impact in drug therapy for the respective population may be submitted as a letter to the editor.
Straightforward phase I pharmacokinetic or pharmacodynamic studies as parts of new drug development will only be considered for publication if the paper involves
-a compound that is interesting and new in some basic or fundamental way, or
-methods that are original in some basic sense, or
-a highly unexpected outcome, or
-conclusions that are scientifically novel in some basic or fundamental sense.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
